Butyrylcholinesterase	butyrylcholinesterase	S_chemicals	O
gene	gene	O	O
mutations	mutations	O	O
in	in	O	O
patients	patients	O	O
with	with	O	O
prolonged	prolonged	O	O
apnea	apnea	O	S_disease
after	after	O	O
succinylcholine	succinylcholine	S_chemicals	O
for	for	O	O
electroconvulsive	electroconvulsive	O	O
therapy	therapy	O	O
.	.	O	O

BACKGROUND	background	O	O
:	:	O	O
patients	patients	O	O
undergoing	undergoing	O	O
electroconvulsive	electroconvulsive	O	O
therapy	therapy	O	O
(	(	O	O
ECT	ect	O	O
)	)	O	O
often	often	O	O
receive	receive	O	O
succinylcholine	succinylcholine	S_chemicals	O
as	as	O	O
part	part	O	O
of	of	O	O
the	the	O	O
anesthetic	anesthetic	S_chemicals	O
procedure	procedure	O	O
.	.	O	O

The	the	O	O
duration	duration	O	O
of	of	O	O
action	action	O	O
may	may	O	O
be	be	O	O
prolonged	prolonged	O	O
in	in	O	O
patients	patients	O	O
with	with	O	O
genetic	genetic	O	O
variants	variants	O	O
of	of	O	O
the	the	O	O
butyrylcholinesterase	butyrylcholinesterase	S_chemicals	O
enzyme	enzyme	S_chemicals	O
(	(	O	O
BChE	bche	O	O
)	)	O	O
,	,	O	O
the	the	O	O
most	most	O	O
common	common	O	O
being	being	O	O
the	the	O	O
K-	k-	O	O
and	and	O	O
the	the	O	O
A-variants	a-variants	O	O
.	.	O	O

The	the	O	O
aim	aim	O	O
of	of	O	O
the	the	O	O
study	study	O	O
was	was	O	O
to	to	O	O
assess	assess	O	O
the	the	O	O
clinical	clinical	O	O
significance	significance	O	O
of	of	O	O
genetic	genetic	O	O
variants	variants	O	O
in	in	O	O
butyrylcholinesterase	butyrylcholinesterase	S_chemicals	O
gene	gene	O	O
(	(	O	O
BCHE	bche	O	O
)	)	O	O
in	in	O	O
patients	patients	O	O
with	with	O	O
a	a	O	O
suspected	suspected	O	O
prolonged	prolonged	O	O
duration	duration	O	O
of	of	O	O
action	action	O	O
of	of	O	O
succinylcholine	succinylcholine	S_chemicals	O
after	after	O	O
ECT	ect	O	O
.	.	O	O

METHODS	methods	O	O
:	:	O	O
a	a	O	O
total	total	O	O
of	of	O	O
13	13	O	O
patients	patients	O	O
were	were	O	O
referred	referred	O	O
to	to	O	O
the	the	O	O
Danish	danish	O	O
Cholinesterase	cholinesterase	S_chemicals	O
Research	research	O	O
Unit	unit	O	O
after	after	O	O
ECT	ect	O	O
during	during	O	O
38	38	O	O
months	months	O	O
.	.	O	O

We	we	O	O
determined	determined	O	O
the	the	O	O
BChE	bche	O	O
activity	activity	O	O
and	and	O	O
the	the	O	O
BCHE	bche	O	O
genotype	genotype	O	O
using	using	O	O
molecular	molecular	O	O
genetic	genetic	O	O
methods	methods	O	O
,	,	O	O
the	the	O	O
duration	duration	O	O
of	of	O	O
apnea	apnea	O	S_disease
,	,	O	O
time	time	O	O
to	to	O	O
sufficient	sufficient	O	O
spontaneous	spontaneous	O	O
ventilation	ventilation	O	O
and	and	O	O
whether	whether	O	O
neuromuscular	neuromuscular	O	O
monitoring	monitoring	O	O
was	was	O	O
used	used	O	O
.	.	O	O

The	the	O	O
duration	duration	O	O
of	of	O	O
apnea	apnea	O	S_disease
was	was	O	O
compared	compared	O	O
with	with	O	O
published	published	O	O
data	data	O	O
on	on	O	O
normal	normal	O	O
subjects	subjects	O	O
.	.	O	O

RESULTS	results	O	O
:	:	O	O
in	in	O	O
11	11	O	O
patients	patients	O	O
,	,	O	O
mutations	mutations	O	O
were	were	O	O
found	found	O	O
in	in	O	O
the	the	O	O
BCHE	bche	O	O
gene	gene	O	O
,	,	O	O
the	the	O	O
K-variant	k-variant	O	O
being	being	O	O
the	the	O	O
most	most	O	O
frequent	frequent	O	O
.	.	O	O

The	the	O	O
duration	duration	O	O
of	of	O	O
apnea	apnea	O	S_disease
was	was	O	O
5	5	O	O
-	-	O	O
15	15	O	O
min	min	O	O
compared	compared	O	O
with	with	O	O
3	3	O	O
-	-	O	O
5.3	5.3	O	O
min	min	O	O
from	from	O	O
the	the	O	O
literature	literature	O	O
.	.	O	O

Severe	severe	O	O
distress	distress	O	O
was	was	O	O
noted	noted	O	O
in	in	O	O
the	the	O	O
recovery	recovery	O	O
phase	phase	O	O
in	in	O	O
two	two	O	O
patients	patients	O	O
.	.	O	O

Neuromuscular	neuromuscular	O	O
monitoring	monitoring	O	O
was	was	O	O
used	used	O	O
in	in	O	O
two	two	O	O
patients	patients	O	O
.	.	O	O

CONCLUSION	conclusion	O	O
:	:	O	O
eleven	eleven	O	O
of	of	O	O
13	13	O	O
patients	patients	O	O
with	with	O	O
a	a	O	O
prolonged	prolonged	O	O
duration	duration	O	O
of	of	O	O
action	action	O	O
of	of	O	O
succinylcholine	succinylcholine	S_chemicals	O
had	had	O	O
mutations	mutations	O	O
in	in	O	O
BCHE	bche	O	O
,	,	O	O
indicating	indicating	O	O
that	that	O	O
this	this	O	O
is	is	O	O
the	the	O	O
possible	possible	O	O
reason	reason	O	O
for	for	O	O
a	a	O	O
prolonged	prolonged	O	O
period	period	O	O
of	of	O	O
apnea	apnea	O	S_disease
.	.	O	O

We	we	O	O
recommend	recommend	O	O
objective	objective	O	O
neuromuscular	neuromuscular	O	O
monitoring	monitoring	O	O
during	during	O	O
the	the	O	O
first	first	O	O
ECT	ect	O	O
.	.	O	O

